daily life performance and public health expenditure. The two major CILD are asthma and chronic obstructive pulmonary diseases (COPD). The World Health Organization estimates that 280 million people suffer from
Statement of the Problem: Chronic Allergic Rhinitis (CAR) represents a worldwide emergency pathology affecting between 10% and 40% of the world population (1). Despite the number of available treatments ... month…
terms of hospital stay and frequent readmissions along with development of complications like bowel obstruction, chronic pain and certain times vascular compromise. This study conducted in the Department of General
syndrome was first described by David Flenley in 1980 refers to the coexistence of Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnoea (OSA). The global prevalence of Overlap syndrome
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death and is estimated to rise to be the third most common cause of death worldwide by 2020. Many
moderate cases of COPD were selected based on spirometry readings and global initiative for chronic obstructive lung disease criteria. The distance walked by patients in 6-minutes was noted before
Obstructive sleep Apnoea ( OSA) is a chronic disorder characterized by intermittent upper airway collapse which impairs ventilation and disrupts sleep. Approximately 3-7% of adult men & 2-5% of adult ... assessed. Sleep…
affects around 2% of children and is a result of partial or complete airway obstruction during sleep, which affects the childâÂ?Â?s ventilation and results in disordered sleep. This ... chronic nocturnal hypoxia and…
anticoagulation. This syndrome has been named warfarin-related nephropathy (WRN), and patients with chronic kidney disease (CKD) appear to be particularly susceptible. WRN is defined as an acute increase ... other…
obesity as well as a number of co-morbidities, most strongly asthma and chronic obstructive pulmonary disease. The monthly prevalence of most RTI symptom categories in the subsequent infection seasons
challenge to eradicate long term health issues in geriatric population such as stroke, chronic obstructive pulmonary disease, heart diseases, osteoarthritis and osteoporosis. Despite failure in advanced medicine and…
Objective: Patients with Chronic Obstructive Pulmonary Disease are a growing group. The main symptom is dyspnoea and subsequent disease is long, often marked by anxiety and reduced quality of life
transplantation are challenged by chronic lung allograft dysfunction (CLAD), whose main phenotype is represented by bronchiolitis obliterans syndrome (BOS), a condition characterized by an irreversible obstructive graft…
BACKGROUND Chronic obstructive pulmonary disease is a chronic debilitating disease that is characterised by poorly reversible airflow limitation. COPD includes emphysema, chronic bronchitis and small airway diseases
associated bronchiectasis. Its pathogenesis is postulated to be enrooted in aberrant connective tissue proliferation. Chronic cough with sputum production, recurrent lower respiratory tract infections and spontaneous…
progression of most severe diseases, such as inflammatory bowel disease (IBD), allergic asthma/chronic obstructive pulmonary disease (COPD), and organ fibrosis that lead to dysfunction and death. Regardless
adenoids are removed. Removal of the adenoids is indicated when they are chronically infected or causing obstruction. Since the earliest descriptions of adenoidectomy, numerous techniques have been described and used
ischemia, toxic injury or extra-renal pathology as pre-renal azotemia, or post-renal obstructive nephropathy. Acute kidney injury is common, harmful and potentially treatable. Even a minor acute reduction ... chronic…
ischemia, toxic injury or extra-renal pathology as pre-renal azotemia, or post-renal obstructive nephropathy. Acute kidney injury is common, harmful and potentially treatable. Even a minor acute reduction ... chronic…
Statement of the Problem: Respiratory dosage forms are at the forefront of asthma and chronic obstructive pulmonary disease treatments, two diseases that afflict worldwide populations. The global sales data estimates
Roflumilast; a selective PDE-4 inhibitor; is approved as an add-on therapy for chronic obstructive pulmonary disease (COPD). The inflammation in COPD and severe asthma is neutrophilic while ... triple inhalation therapy…
weakness of the sinus node, adhesive process in pericardium, adhesive process in pleural cavity, chronic obstructive bronchitis of the lungs (difficult long term one lung ventilation), atrium size less than
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.